5ULA
Crystal Structure of the First Bromodomain of Human BRD4 in Complex With Cyclic Vinylogous Amide Inhibitor MS402
Summary for 5ULA
Entry DOI | 10.2210/pdb5ula/pdb |
Descriptor | Bromodomain-containing protein 4, 3-chloranyl-~{N}-(4-methoxyphenyl)-4-[(2-methyl-3-oxidanylidene-cyclopenten-1-yl)amino]benzamide (3 entities in total) |
Functional Keywords | bromodomain, inhibitor, transcription, transcription-inhibitor complex, transcription/inhibitor |
Biological source | Homo sapiens (Human) |
Cellular location | Nucleus: O60885 |
Total number of polymer chains | 2 |
Total formula weight | 30940.42 |
Authors | Plotnikov, A.N.,Joshua, j.,Zhou, M.-M. (deposition date: 2017-01-24, release date: 2017-03-22, Last modification date: 2024-03-06) |
Primary citation | Cheung, K.,Lu, G.,Sharma, R.,Vincek, A.,Zhang, R.,Plotnikov, A.N.,Zhang, F.,Zhang, Q.,Ju, Y.,Hu, Y.,Zhao, L.,Han, X.,Meslamani, J.,Xu, F.,Jaganathan, A.,Shen, T.,Zhu, H.,Rusinova, E.,Zeng, L.,Zhou, J.,Yang, J.,Peng, L.,Ohlmeyer, M.,Walsh, M.J.,Zhang, D.Y.,Xiong, H.,Zhou, M.M. BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice. Proc. Natl. Acad. Sci. U.S.A., 114:2952-2957, 2017 Cited by PubMed: 28265070DOI: 10.1073/pnas.1615601114 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.5 Å) |
Structure validation
Download full validation report